Trials / Conditions / Relapsed Mantle Cell Lymphoma
Relapsed Mantle Cell Lymphoma
3 registered clinical trials studyying Relapsed Mantle Cell Lymphoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma NCT05471843 | BeiGene | Phase 1 / Phase 2 |
| Recruiting | Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intol NCT05249959 | Fondazione Italiana Linfomi - ETS | Phase 2 |
| Completed | Study to Evaluate Efficacy and Safety of BGB-3111 in Participants With Relapsed or Refractory Mantle Cell Lymp NCT03206970 | BeiGene | Phase 2 |